Tag: immunotherapy
A Message for Food Allergy Sufferers: Now is Not the Time
Two common sense recommendations until the coronavirus crisis abates.
Aimmune Licenses Exclusive Worldwide Rights to Xencor’s XmAb®7195 for the Development...
“In-licensing AIMab7195 demonstrates our commitment to enriching our pipeline and strengthening Aimmune’s global leadership in the evolving therapeutic landscape of food allergy treatments.”
Allergy Therapeutics Publishes Encouraging New Data for Peanut Allergy Vaccine Candidate
"This study indicates a paradigm shift by addressing peanut allergy via a vaccination concept instead of classic desensitisation..."
DBV Technologies Announces FDA Acceptance of BLA filing for Viaskin Peanut...
If approved, Viaskin Peanut would be the first and only epicutaneous immunotherapy indicated for this potentially life-threatening condition in children.
New Peanut Allergy Treatment Passes Phase 2 Trial, Shows Effectiveness and...
UNC School of Medicine researchers show that tiny under-the-tongue doses of peanut protein can offer safe and substantial protection against peanut allergy.
Fare Responds to Final ICER Review of Breakthrough Peanut Allergy Therapies
FARE expresses its deep concerns with the final evidence report on two breakthrough peanut allergy therapies issued Wednesday by ICER.
Asthma and Allergy Foundation of America Responds to Premature ICER Review...
The AAFA addresses concerns
regarding the Final Evidence Report released by the ICER.
Asthma and Allergy Foundation of America Elevates Patient Voice in ICER...
Affirms Burden of Food Allergies on Families, Patients, and Caregivers.
Must Hear: Interview with Stanford Immunologist Dr Kari Nadeau – Defeating...
Dr Kari Nadeau, who runs the Sean Parker Center for Allergy and Asthma Research at Stanford University, takes us on a tour...
Phase I Trial for New Peanut Allergy Immunotherapy Results in No...
Research details phase one study of peptide-based immunotherapy, which is designed to remove risks of acute reactions during treatment.
